FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

40228011000036105: Scheriproct 0.19% / 0.5% (cinchocaine hydrochloride 5 mg / 1 g + prednisolone hexanoate 1.9 mg / 1 g) ointment (trade product unit of use)


Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
192468011000036110 Scheriproct 0.19% / 0.5% ointment en Synonym Active Case sensitive Australian Medicines Terminology module
192470011000036116 Scheriproct 0.19% / 0.5% (cinchocaine hydrochloride 5 mg / 1 g + prednisolone hexanoate 1.9 mg / 1 g) ointment (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Scheriproct 0.19% / 0.5% ointment has Australian BoSS prednisolone hexanoate true Inferred relationship Some 1430928542
Scheriproct 0.19% / 0.5% ointment has intended active ingredient prednisolone hexanoate true Inferred relationship Some 1430928542
Scheriproct 0.19% / 0.5% ointment has unit of use continuous true Inferred relationship Some 1608875511
Scheriproct 0.19% / 0.5% ointment has Australian BoSS cinchocaine hydrochloride true Inferred relationship Some 1608875510
Scheriproct 0.19% / 0.5% ointment Is a trade product unit of use true Inferred relationship Some
Scheriproct 0.19% / 0.5% ointment Is a Scheriproct 0.19% / 0.5% true Inferred relationship Some
Scheriproct 0.19% / 0.5% ointment Is a cinchocaine hydrochloride 5 mg / 1 g + prednisolone hexanoate 1.9 mg / 1 g ointment (medicinal product unit of use) true Inferred relationship Some
Scheriproct 0.19% / 0.5% ointment has manufactured dose form ointment true Inferred relationship Some
Scheriproct 0.19% / 0.5% ointment has intended active ingredient cinchocaine true Inferred relationship Some 1608875510

Inbound Relationships Type Active Source Characteristic Refinability Group
Scheriproct 0.19% / 0.5% (cinchocaine hydrochloride 5 mg / 1 g + prednisolone hexanoate 1.9 mg / 1 g) ointment, 10 g (trade product pack) has TPUU True Scheriproct 0.19% / 0.5% ointment Inferred relationship Some 1
Scheriproct 0.19% / 0.5% ointment, 30 g has TPUU True Scheriproct 0.19% / 0.5% ointment Inferred relationship Some 1
Scheriproct 0.19% / 0.5% ointment, 30 g, tube has TPUU True Scheriproct 0.19% / 0.5% ointment Inferred relationship Some 1
Scheriproct 0.19% / 0.5% (cinchocaine hydrochloride 5 mg / 1 g + prednisolone hexanoate 1.9 mg / 1 g) ointment, 10 g, tube (containered trade product pack) has TPUU True Scheriproct 0.19% / 0.5% ointment Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start